Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes
- DOI
- 10.1080/2162402x.2021.1940676
- Published
- 2021-01
- Container
- OncoImmunology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/2162402x.2021.1940676,
title = {Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes},
author = {L Marotte and M Capitao and C Deleine and T Beauvais and G Cadiou and J. Perrin and M Chérel and E Scotet and Y Guilloux and F Bruchertseifer and A Morgenstern and A Jarry and J. Gaschet and N Labarriere},
year = {2021},
journal = {OncoImmunology},
doi = {10.1080/2162402x.2021.1940676},
url = {https://doi.org/10.1080/2162402x.2021.1940676}
}RIS
TY - JOUR TI - Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes AU - L Marotte AU - M Capitao AU - C Deleine AU - T Beauvais AU - G Cadiou AU - J. Perrin AU - M Chérel AU - E Scotet AU - Y Guilloux AU - F Bruchertseifer AU - A Morgenstern AU - A Jarry AU - J. Gaschet AU - N Labarriere PY - 2021 JO - OncoImmunology DO - 10.1080/2162402x.2021.1940676 UR - https://doi.org/10.1080/2162402x.2021.1940676 ER -
APA
Marotte, L., Capitao, M., Deleine, C., Beauvais, T., Cadiou, G., Perrin, J., Chérel, M., Scotet, E., Guilloux, Y., Bruchertseifer, F., Morgenstern, A., Jarry, A., Gaschet, J., & Labarriere, N. (2021). Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes. OncoImmunology. https://doi.org/10.1080/2162402x.2021.1940676
Source records
- crossref · retrieved 2026-11-10T15:06:46.423Z